Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Parenteral administration (subcutaneous or intravenous) provides direct systemic availability
Additional Safety Information: Not recommended for individuals who are pregnant, breastfeeding, or planning to become pregnant or breastfeed
It does not sell peptides, for now at least
Six-month marker comparison
The retatrutide dose chart shows expected responses at each dose level
cautious titration recommended RxList Sermorelin treatment duration: pediatric studies 612 months daily therapy with sustained effect
US$ 21.34
US$ 26.83
US$ 20.74
